[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 38 pages

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and In...

May 2022 104 pages

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 328 pages

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 39 pages

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 117 pages

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H1 Receptor (HRH1) Drugs in Development by Therapy...

May 2022 69 pages

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H3 Rece...

May 2022 41 pages

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hist...

May 2022 47 pages

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs...

May 2022 202 pages

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 36 pages

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy A...

May 2022 47 pages

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 47 pages

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Develop...

May 2022 51 pages

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA...

May 2022 38 pages

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA,...

May 2022 59 pages

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 42 pages

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Cytomegalovirus Glycoprotein H (gH) Drugs...

May 2022 35 pages

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 46 pages

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 131 pages

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E6 (E6) Drugs in Develo...

May 2022 65 pages

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E7 (E7) Drugs in Develo...

May 2022 77 pages

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Ta...

May 2022 35 pages

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS Co...

May 2022 38 pages

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS corona...

May 2022 40 pages

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 35 pages

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages...

May 2022 36 pages

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 146 pages

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 42 pages

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 64 pages

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 41 pages

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 41 pages

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA...

May 2022 42 pages

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target,...

May 2022 63 pages

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 36 pages

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY IgA Nephropathy (Berger's Disease) Drugs in Development by Stages, Target, MoA...

May 2022 73 pages

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 38 pages

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Develo...

May 2022 49 pages

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by...

May 2022 38 pages

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 39 pages

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA...

May 2022 39 pages

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 42 pages

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 36 pages

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 170 pages

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Influenza M2 Proton Channel Drugs in Development by Therapy A...

May 2022 36 pages

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 269 pages

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA,...

May 2022 46 pages

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Like Growth...

May 2022 65 pages

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Receptor (IR or CD220 or IN...

May 2022 219 pages

Filters

Clear all

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

—

Date

—

Pages

—

Offers

1
280
1
1